Erudio Healtherudio.com
Drug
Vandetanib trials: what clinicians said in public
No HCP commentary report on a trial studying vandetanib yet. Erudio has found public clinician commentary on 1 clinical trial studying vandetanib: LIBRETTO-531. Its page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| LIBRETTO-531 NCT04211337 · Loxo Oncology, Inc. DeepView → | kinase inhibitor-naïve advanced RET-mutant medullary thyroid cancer | Phase 3 | Deep | View | |||